New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 24, 2024 - Teva launched an authorized brand alternative of Novo Nordisk’s Victoza (liraglutide) injection.
Download PDF
Return to publications
